Why was the I Sware biopic risky?
Kirk Jones’ decision to make I Sware—and to build it around Robert Aramayo—was framed as a difficult creative leap.
From the information provided, the project faced inherent uncertainty: it’s a 2025 biopic with a perfect Rotten Tomatoes Tomatometer score (100%), but the director’s willingness to proceed is described as “risky,” implying that the subject matter and/or approach required betting on audience buy-in rather than relying on a guaranteed blockbuster formula.
The critical context: awards-ready performance
The materials emphasize that the film stars Robert Aramayo, and that his performance is award-winning—separately, he’s been linked to winning Best Actor. That kind of lead commitment is often what justifies high-risk filmmaking: instead of hedging with a safer casting choice or a more commercially predictable story, the production leaned on a performance strong enough to carry a biopic.
Why the risk matters for audiences
A biopic can easily become either too distant (celebrating the person without drama) or too mired in controversy (where audience tolerance varies widely). By pairing a serious tone with an acclaimed central performance, the film is designed to convert viewers who might otherwise skip smaller or less-known biographical stories.
The news signal for industry watchers is that I Sware is being treated as quality-led despite the risk factor. A 100% score and an awards-caliber lead indicate that whatever uncertainties surrounded the decision to make it, the end product landed in a place that critics and award pathways could reward.